Shareholders convened to approve capital increase, amended articles, and public share issue.
G.D. Pharmaceuticals Limited held a Special General Meeting at its registered office in Tripureshwor, Kathmandu. Shareholders considered proposals to increase the authorised and issued capital, amend the Memorandum and Articles of Association, and issue shares to the general public through an IPO.
Share this article:
Attachments & Regulatory Documents
- Notice of Special General Meeting31 May 2026 Download PDF